France
· Delayed Price · Currency is EUR Facephi Biometria Statistics
Total Valuation
Facephi Biometria has a market cap or net worth of EUR 35.78 million. The enterprise value is 52.35 million.
| Market Cap | 35.78M |
| Enterprise Value | 52.35M |
Important Dates
The next estimated earnings date is Monday, November 25, 2024.
| Earnings Date | Nov 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 19.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.87 |
| EV / Sales | 1.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of 1.06.
| Current Ratio | 0.69 |
| Quick Ratio | 0.68 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.43 |
Financial Efficiency
Return on equity (ROE) is -41.21% and return on invested capital (ROIC) is -15.95%.
| Return on Equity (ROE) | -41.21% |
| Return on Assets (ROA) | -10.90% |
| Return on Capital (ROIC) | -15.95% |
| Revenue Per Employee | 119,450 |
| Profits Per Employee | -22,358 |
| Employee Count | 264 |
| Asset Turnover | 0.75 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.40% in the last 52 weeks. The beta is 1.20, so Facephi Biometria's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -36.40% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 45.96 |
| Average Volume (20 Days) | 597 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Facephi Biometria had revenue of EUR 31.53 million and -5.90 million in losses.
| Revenue | 31.53M |
| Gross Profit | 27.87M |
| Operating Income | -7.33M |
| Pretax Income | -8.62M |
| Net Income | -5.90M |
| EBITDA | -6.42M |
| EBIT | -7.33M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 629,738 in cash and 17.20 million in debt, giving a net cash position of -16.57 million.
| Cash & Cash Equivalents | 629,738 |
| Total Debt | 17.20M |
| Net Cash | -16.57M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 16.22M |
| Book Value Per Share | n/a |
| Working Capital | -8.52M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 88.36%, with operating and profit margins of -23.23% and -18.72%.
| Gross Margin | 88.36% |
| Operating Margin | -23.23% |
| Pretax Margin | -27.33% |
| Profit Margin | -18.72% |
| EBITDA Margin | -20.37% |
| EBIT Margin | -23.23% |
| FCF Margin | n/a |
Dividends & Yields
Facephi Biometria does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Facephi Biometria has an Altman Z-Score of 0.64. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.64 |
| Piotroski F-Score | n/a |